Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of HMPL-004 added to mesalamine in mild to moderate ulcerative colitis
2013-002116-27Phase 3Terminated
- Sponsor
- Nutrition Science Partners Limited
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of andrographolide in autoimmune colitis (3 arms), sponsored by Nutrition Science Partners Limited. Primary endpoint: Clinical remission at Week 8. Started Jun 2013; status: terminated.
02
Drugs
andrographolide
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2013-002116-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002116-27.